Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Sydnexis is engaged in the development of a proprietary treatment for pediatric progressive myopia.
Theseus Pharmaceuticals is a technology-based company.
Zavante focuses on developing novel therapies to improve the outcomes of hospitalized patients.
Alphaeon offers credit to people seeking medical and dental care.
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Velicept Therapeutics is a privately held clinical development
Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.
Amphora Medical is a Minnesota-based developer of medical devices and instruments.
KaNDy Therapeutics is a clinical-stage company focused on optimizing the potential of NT-814.
Murj is a digital health company working on a solution for cardiac care.
Neurana Pharmaceuticals is currently developing a novel treatment for acute muscle spasms.
Cydan is an orphan drug accelerator focused on identifying and de-risking compounds with therapeutic and commercial potential.
Sympara Medical is a medical company that focuses on developing novel therapies for hypertension.
PreCision Dermatology is a fully-integrated dermatology company developing diagnostics and therapeutics.
Longitude Capital has invested in 62 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Longitude Capital's top investment sectors include Health Care, Biotechnology, Medical, Pharmaceutical, Therapeutics. The firm invests across 10 different industry categories.
Among tracked funding rounds, Aimmune Therapeutics received $200.0M in a Post Ipo Equity round. Longitude Capital's total known invested capital is $3.8B.
Longitude Capital's average investment size is $76.9M across its portfolio of 62 companies.
Recent Longitude Capital portfolio additions include Sydnexis, Theseus Pharmaceuticals, Zavante Therapeutics, Alphaeon, Aimmune Therapeutics. These companies were founded in 2020 or later.